07 Oct New molecular respiratory panel ready for the US market

Posted at 07:07h in Board, Novacyt Group, Products by

Multiplex test identifies up to 37 respiratory pathogens

Paris, France and Camberley, UK – 7 October 2019 – Novacyt (ALTERNEXT: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces the succesful development of a new molecular diagnostic multiplex test for respiratory infections, which is ready for launch in North America in time for the US cold and flu season.

https://novacyt.com/wp-content/uploads/2019/10/Novacyt-respiratory-panel-PR-Final-7.10.19-ENGLISH.pdf